2021
SDHC Methylation Pattern in Patients With Carney Triad
DAUMOVA, Magdalena, Marian SVAJDLER, Pavel FABIAN, Leoš KŘEN, Iva BABANKOVA et. al.Základní údaje
Originální název
SDHC Methylation Pattern in Patients With Carney Triad
Autoři
DAUMOVA, Magdalena (203 Česká republika), Marian SVAJDLER (203 Česká republika), Pavel FABIAN (203 Česká republika), Leoš KŘEN (203 Česká republika, domácí), Iva BABANKOVA (203 Česká republika), Marta JEŽOVÁ (203 Česká republika, domácí), Monika SEDIVCOVA (203 Česká republika), Tomas VANECEK (203 Česká republika), Kristyna BEHENSKA (203 Česká republika), Michal MICHAL (203 Česká republika) a Ondrej DAUM (203 Česká republika, garant)
Vydání
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2021, 1541-2016
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.992
Kód RIV
RIV/00216224:14110/21:00124184
Organizační jednotka
Lékařská fakulta
UT WoS
000696558400009
Klíčová slova anglicky
Carney triad; somatic mosaicism; SDHC; methylation
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 2. 2022 10:39, Mgr. Tereza Miškechová
Anotace
V originále
Carney triad is a multitumor syndrome affecting almost exclusively young women in a nonfamilial setting, which manifests by multifocal gastric gastrointestinal stromal tumors, paragangliomas, and pulmonary chondroma. The Carney triad-associated tumors are characterized by a deficiency of the mitochondrial succinate dehydrogenase enzymatic complex. Recently, it has been observed that the deficiency results from epigenetic silencing of the SDHC gene by its promoter hypermethylation. To elucidate anatomic distribution of SDHC promoter methylation in Carney triad patients and thus to shed some light on the possible natural development of this epigenetic change, both neoplastic and available non-neoplastic tissues of 3 patients with Carney triad were tested for hypermethylation at the SDHC promoter site. SDHC promoter hypermethylation was proven in all tumors studied. Lack of SDHC epigenetic silencing in the non-neoplastic lymphoid and duodenal tissue (ie, tissues not involved in the development of Carney triad-associated tumors) together with the finding of SDHC promoter hypermethylation in the non-neoplastic gastric wall favors the hypothesis of postzygotic somatic mosaicism as the biological background of Carney triad; it also offers an explanation of the multifocality of gastrointestinal stromal tumors of the stomach occurring in this scenario as well. However, the precise mechanism responsible for the peculiar organ-specific distribution of Carney triad-associated tumors is still unknown.